SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-18-010573
Filing Date
2018-09-27
Accepted
2018-09-27 18:32:32
Documents
1
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 6677
  Complete submission text file 0001654954-18-010573.txt   7989
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Mazar Andrew Paul (Reporting) CIK: 0001727393 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55866 | Film No.: 181092145